Currently out of the existing stock ratings of Matthew Henriksson, 4 are a BUY (100%).

Matthew Henriksson

Work Performance Price Targets & Ratings Chart

Analyst Matthew Henriksson works at CITI with a stock forecast success ratio of 75% fulfilled within 111 days on average.

Matthew Henriksson’s has documented 8 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GMED, Globus Medical at 05-Aug-2021.

Wall Street Analyst Matthew Henriksson

Analyst best performing recommendations are on GMED (GLOBUS MEDICAL).
The best stock recommendation documented was for GMED (GLOBUS MEDICAL) at 2/18/2021. The price target of $77 was fulfilled within 127 days with a profit of $13.5 (21.26%) receiving and performance score of 1.67.

Average potential price target upside

GMED Globus Medical

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

60

$5.54 (10.17%)

53

8 days ago

8/17 (47.06%)

$5 (9.09%)

403

Buy

64

$9.54 (17.52%)

61

8 days ago

4/6 (66.67%)

$9 (16.36%)

128

Buy

75

$20.54 (37.72%)

70

4 months 9 days ago

4/9 (44.44%)

$23.69 (46.17%)

105

Buy

86

$31.54 (57.91%)

77

4 months 17 days ago

14/19 (73.68%)

$32.8 (61.65%)

232

Hold

58

$3.54 (6.50%)

63

5 months 14 days ago

3/7 (42.86%)

$7.99 (15.98%)

116

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Matthew Henriksson?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?